Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice.

Articles
Brown, B., Gabra, M. I., & Pellman, H., (2017). Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice. Papillomavirus Research, 3, 42-45.
Despite the effectiveness and availability of the Human Papillomavirus (HPV) vaccine, HPV remains the most common sexually transmitted infection in the United States and has the l…

Human papillomavirus (HPV) vaccine initiation in minority Americans.

Articles
De, P., & Budhwani, H., (2017). Human papillomavirus (HPV) vaccine initiation in minority Americans. Public Health, 144, 86-91.
Objectives: Transmission of the human papillomavirus (HPV) is a significant public health concern. HPV is preventable through a series of vaccinations; however, knowledge gaps exi…

Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.

Articles
Chesson, H. W., Meites, E., Ekwueme, D. U., Saraiya, M., & Markowitz, L. E., (2018). Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States. Vaccine, 36, 4362-4368.
Introduction: In the United States, routine human papillomavirus (HPV) vaccination is recommended for females and males at age 11 or 12 years; the series can be started at age 9 y…

“HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papilloma virus vaccination.

Articles
Hendry, M., Lewis, R., Clements, A., Damery, S., & Wilkinson, C., (2013). “HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papilloma virus vaccination. Vaccine, 31, 5152-5167.
Background and objective: Two human papillomavirus vaccines were licenced in 2006/2007 for cervical cancer prevention. National vaccination programmes for schoolgirls were subsequ…

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papilloma virus (HPV) vaccine schedule in low and middle-income countries.

Articles
Gallagher, K. E., Kelly, H., Cocks, N., Dixon, S., Mounier-Jack, S., Howard, N., & Watson-Jones, D., (2018). Vaccine programme stakeholder perspectives on a hypothetical single-dose human papilloma virus (HPV) vaccine schedule in low and middle-income countries. Papillomavirus Research, 6, 33-40.
Background: The World Health Organization (WHO) recommends a 2-dose HPV vaccine schedule for girls aged 9–14 years. As randomised controlled trials assessing the immunogenicity an…

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.

Articles
Gallagher, K. E., Howard, N., Kabakama, S., Mounier-Jack, S., Burchett, H. E. D., LaMontagne, D. S., & Watson-Jones, D., (2017). Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016. Papillomavirus Research, 4, 72-78.
Introduction: Since 2007, HPV vaccine has been available to low and middle income countries (LAMIC) for small-scale ‘demonstration projects’, or national programmes. We analysed c…

Understanding human papilloma virus vaccine uptake.

Articles
Fisher, W. A., (2012). Understanding human papilloma virus vaccine uptake. Vaccine, 30S, F149-F156.
The current chapter reviews research on correlates of human papillomavirus (HPV) vaccine uptake. Findings are organized within an Information—Motivation—Behavioral Skills (IMB) mo…

Early outcomes of a multilevel human papilloma virus vaccination pilot intervention in federally qualified health centers.

Articles
Fisher-Borne, M., Preiss, A. J., Black, M., Roberts, K., & Saslow, D., (2018). Early outcomes of a multilevel human papilloma virus vaccination pilot intervention in federally qualified health centers. Academic Pediatrics, 18(2S), S79-S84.
OBJECTIVE: Human papillomavirus (HPV) vaccine coverage in the United States remains low compared with other adolescent vaccines. As the largest primary care network in the United …

Human papillomavirus vaccination: Narrative review of studies on how providers’ vaccine communication affects attitudes and uptake.

Articles
Dempsey, A. F., & O’Leary, S. T., (2018). Human papillomavirus vaccination: Narrative review of studies on how providers’ vaccine communication affects attitudes and uptake. Academic Pediatrics, 18 (S2), S23-S27.
The burden of human papillomavirus (HPV) infections is substantial, causing thousands of cancers and deaths in the United States yearly. Safe and effective vaccines exist, yet rem…

Human papillomavirus vaccine acceptability among parents of adolescent girls in a rural area, Mysore, India.

Articles
Degarege, A., Krupp, K., Fennie, K., Srinivas, V., Li, T., Stephens, D. P., Marlow, L. A. V., Arun, A., & Madhivanan, P., (2018). Human papillomavirus vaccine acceptability among parents of adolescent girls in a rural area, Mysore, India. Journal of Pediatric and Adolescent Gynecology, 31, 583-591.
Study Objective: The purpose of this study was to examine factors predicting human papillomavirus (HPV) vaccine acceptability among parents of adolescent girls in a rural area in …

Virtual Oceania

Introductory Workshop

May 29th - 31st, 2024

Learn More

Virtual North America

Introductory Workshop

Jun 3rd - 5th, 2024

Learn More
Site Courtesy of
McKenzie-Mohr & Associates

Expertise in Community-Based Social Marketing